Drug Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ENZ | F | Enzo Biochem, Inc. | 0.00 | |
NMRA | F | Neumora Therapeutics, Inc. | 0.33 | |
TVGN | F | Tevogen Bio Holdings Inc. | -1.64 | |
SPRC | F | SciSparc Ltd. | 0.00 | |
BTAI | F | BioXcel Therapeutics, Inc. | 0.39 | |
ATHA | F | Athira Pharma, Inc. | 0.00 | |
IMRX | F | Immuneering Corporation | 5.13 | |
NOTV | F | Inotiv, Inc. | 2.64 | |
ABCL | F | AbCellera Biologics Inc. | 4.68 | |
AMPH | F | Amphastar Pharmaceuticals, Inc. | -0.47 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Semiconductor Equipment & Materials
Related Stock Lists:
Biotechnology
Pharmaceutical
Biopharmaceutical
Health Sciences
Pharmacology
Biology
Disease
Life Sciences
Medication
Pharmaceutical Products
Pharmaceutical Sciences
Pharmacy
Technology Solutions
Active Pharmaceutical Ingredients
Advanced Solid Tumors
Antibodies
Applied Genetics
Bank
Bioinformatics
Biopharmaceutical Products
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
XPH | D | SPDR S&P Pharmaceuticals ETF | 6.7 | |
PILL | D | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 5.68 | |
ROYA | A | Tema Global Royalties ETF | 5.59 | |
IHE | C | iShares U.S. Pharmaceutical ETF | 5.25 | |
PINK | C | Simplify Health Care ETF | 3.31 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Semiconductor Equipment & Materials
Related Stock Lists:
Biotechnology
Pharmaceutical
Biopharmaceutical
Health Sciences
Pharmacology
Biology
Disease
Life Sciences
Medication
Pharmaceutical Products
Pharmaceutical Sciences
Pharmacy
Technology Solutions
Active Pharmaceutical Ingredients
Advanced Solid Tumors
Antibodies
Applied Genetics
Bank
Bioinformatics
Biopharmaceutical Products
- Drug Development
Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles